XML 106 R73.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details) - Schedule of deferred tax assets - Blade Therapeutics, Inc. [Member] - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:    
Net operating loss carryforwards $ 29,673 $ 22,265
Research and development credits carryforwards 4,719 3,272
Accruals and other 698 765
Fixed assets 145
Total deferred income tax assets 35,235 26,302
Less: valuation allowance (35,235) (26,241)
Total deferred tax assets 61
Deferred tax liabilities:    
Fixed assets (61)
Net deferred tax assets